| Kelly Michelle Mcdaniel, CRNA | |
|
632 N 12th St # 230, Murray, KY 42071-1651 | |
| (270) 627-0150 | |
| Not Available |
| Full Name | Kelly Michelle Mcdaniel |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 632 N 12th St # 230, Murray, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962718908 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3006605 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates, Psc | 3678569068 | 49 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Entity Name | Central Kentucky Anesthesia P.s.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518083161 PECOS PAC ID: 4880508712 Enrollment ID: O20031115000040 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Entity Name | Trigg County Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20031205000118 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Entity Name | Anesthesia Associates, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902991169 PECOS PAC ID: 3678569068 Enrollment ID: O20040421001618 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Entity Name | Trigg County Hospital, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20080103000025 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Entity Name | Murray Anesthetists Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164701447 PECOS PAC ID: 6709057854 Enrollment ID: O20110921000110 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Michelle Mcdaniel, CRNA 632 N 12th St # 230, Murray, KY 42071-1651 Ph: (270) 627-0150 | Kelly Michelle Mcdaniel, CRNA 632 N 12th St # 230, Murray, KY 42071-1651 Ph: (270) 627-0150 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for accelerated review of ARIAD's investigational BCR-ABL inhibitor, ponatinib, in patients with resistant or intolerant chronic myeloid leukemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL).
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
The most unstable joint in the body, the shoulder, is most at risk for dislocation and subluxations. Current shoulder supports immobilize a patient's shoulder.
Cell cannibalism in tumor samples has been observed for over a century, yet this unusual behavior is not well studied.
› Verified 4 days ago
Edward S Parrish Iii, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 803 Poplar St, Murray, KY 42071 Phone: 270-762-1100 | |
Mr. Adam Shane David, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 859-948-8389 | |
Margaret L. Daniel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 831-431-3243 | |
Ashley Jane Young, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Suite 400, Murray, KY 42071 Phone: 270-293-9637 | |
Jennifer A Green, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-748-6851 | |
Maria D Jennings, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-227-6405 | |
Amy Lockwood, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 632 N 12th St # 230, Murray, KY 42071 Phone: 270-705-9065 |